Welcome to our dedicated page for Hca Healthcare SEC filings (Ticker: HCA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
HCA Healthcare’s sheer scale—hundreds of hospitals, thousands of beds, and billions in Medicare reimbursements—means its SEC disclosures overflow with complex details about payer mix, same-facility admissions, malpractice reserves, and regulatory audits. Finding the one line on outpatient surgery margins or the note on cyber breaches can feel impossible.
Stock Titan rescues your schedule. Our AI digests every HCA Healthcare annual report 10-K simplified, flags shifts in reimbursement rates inside the HCA Healthcare quarterly earnings report 10-Q filing, and delivers HCA Healthcare Form 4 insider transactions real-time alerts the second they hit EDGAR. Curious about sudden executive sales? The platform highlights HCA Healthcare executive stock transactions Form 4. Need context on a facility divestiture? We attach plain-English notes to the latest HCA Healthcare 8-K material events explained. Our AI-powered summaries translate technical accounting into clear language—ideal for understanding HCA Healthcare SEC documents with AI rather than wading through footnotes.
Investors use these insights to monitor reimbursement exposure, benchmark occupancy trends, and compare segment margins quarter over quarter. Whether you’re researching HCA Healthcare proxy statement executive compensation before a vote or seeking an HCA Healthcare earnings report filing analysis to project free cash flow, every document is indexed, searchable, and updated in real time. That includes the must-track HCA Healthcare insider trading Form 4 transactions for pattern analysis. Complex filings, clarified—so you can act before the market does.
HCA Healthcare has filed a Form S-8 to register an additional 13,150,000 shares of common stock ($0.01 par value) under its 2020 Stock Incentive Plan for Key Employees. This amendment to the plan became effective April 24, 2025.
Key details of the filing:
- Registration is for additional shares authorized under the amended 2020 Stock Plan
- Company is classified as a large accelerated filer
- Filing incorporates by reference multiple documents including the 2024 Annual Report, Q1 2025 Quarterly Report, and recent Current Reports
The filing includes executive signatures from key leadership including Samuel N. Hazen (CEO), Michael A. Marks (CFO), and Thomas F. Frist III (Chairman). This stock plan registration indicates HCA Healthcare's continued investment in employee compensation and retention through equity-based incentives.
FAQ
What is the current stock price of Hca Healthcare (HCA)?
What is the market cap of Hca Healthcare (HCA)?
